METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Clinical trials for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA explained in plain language.
Never miss a new study
Get alerted when new METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA trials appear
Sign up with your email to follow new studies for METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New cocktail targets tough pancreatic cancer
Disease control Not yet recruitingThis phase 3 trial tests a new combination of drugs (chiauranib, an immunotherapy, and two chemotherapies) as a first treatment for people with metastatic pancreatic cancer that has spread. About 558 adults will take part to see if the combo helps them live longer and controls th…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE3 • Sponsor: Chipscreen Biosciences, Ltd. • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a new drug, telisotuzumab adizutecan, combined with standard chemotherapy (FOLFOX) in people with advanced pancreatic cancer that has spread. About 900 adults will be randomly assigned to receive either the new combination or standard treatment. The goal is to se…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE2, PHASE3 • Sponsor: AbbVie • Aim: Disease control
Last updated May 26, 2026 11:47 UTC
-
New hope for tough pancreatic cancer? early trial launches
Disease control Not yet recruitingThis early-phase trial tests two drugs (cosibelimab and balixafortide) together in people with metastatic pancreatic cancer that has worsened after standard chemotherapy. The main goal is to find the safest dose and check for side effects. About 24 adults will take part in this s…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1 • Sponsor: Arsen Osipov • Aim: Disease control
Last updated May 26, 2026 11:44 UTC
-
New hope for pancreatic cancer: drug combo trial launches
Disease control Not yet recruitingThis study tests a new combination treatment for people with metastatic pancreatic cancer that has spread to other parts of the body. The treatment combines a drug called rimegepant with standard chemotherapy (AG). The goal is to see if this combination can slow down the cancer's…
Matched conditions: METASTATIC PANCREATIC DUCTAL ADENOCARCINOMA
Phase: PHASE1, PHASE2 • Sponsor: Xiuchao Wang • Aim: Disease control
Last updated May 19, 2026 11:59 UTC